• PDHA1 Succinylation–Driven α-KGA Accumulation Suppresses Mac

  2026-08-04

  This study elucidates how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma leads to alpha-ketoglutarate (α-KGA) accumulation, which suppresses macrophage antigen presentation by activating OXGR1-MAPK signaling. These findings reveal a metabolic-immune axis underlying immune escape and suggest that targeting PDHA1 succinylation could improve chemotherapy sensitivity.

• β-Amanitin in RNA Polymerase II Studies: Protocols & Pitfall

  2026-08-04

  β-Amanitin is a gold-standard tool for interrogating transcriptional regulation and enabling next-generation toxicology workflows. This article bridges high-resolution mRNA synthesis inhibition assays with rapid detection strategies, offering actionable protocols and troubleshooting insights for molecular biology labs.

• Optimizing Assays with HyperFluor™ 488 Rabbit Anti-Goat IgG

  2026-08-03

  The HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody delivers unmatched sensitivity and specificity for fluorescence-based immunoassays, streamlining workflows from Western blotting to advanced immunohistochemistry. By leveraging Alexa Fluor 488 conjugation and robust protocol flexibility, researchers can overcome common detection hurdles and extract richer biological insights.

• Veratridine: Voltage-Gated Sodium Channel Opener in Research

  2026-08-03

  Veratridine stands out as a robust voltage-gated sodium channel opener for dissecting sodium channel dynamics, excitotoxicity, and cancer cell signaling. This article details practical workflows, protocol refinements, and troubleshooting strategies that empower researchers to harness veratridine’s unique bioactivity across neuroscience and oncology applications.

• Urinary CQD Nanosensors Enable Early, Noninvasive Detection

  2026-08-02

  Wu et al. present a minimally invasive nanosensor that detects early atherosclerosis (AS) by responding to protease activity in urine, using carbon quantum dots for sensitive, fluorescence-based readout. This approach offers a practical alternative to traditional, invasive AS diagnostics and demonstrates strong translational potential.

• Dibutyryl-cAMP, Sodium Salt: Insights into Alzheimer’s Disea

  2026-08-01

  Explore how Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) advances cAMP signaling pathway research and offers new perspectives for modeling Alzheimer’s disease mechanisms. This article uniquely bridges molecular assay design with translational neurodegeneration insights.

• Reliable Lab Solutions with Dexamethasone (DHAP) SKU A2324

  2026-07-31

  This article delivers a scenario-driven, evidence-based guide to using Dexamethasone (DHAP) (SKU A2324) for reproducible cell viability, proliferation, and neuroinflammation assays. Grounded in real laboratory challenges, it highlights how APExBIO’s Dexamethasone (DHAP) supports robust data generation and workflow optimization for biomedical researchers.

• Minoxidil Sulphate in Vascular K+ Channel Research: Beyond H

  2026-07-31

  Explore Minoxidil sulphate as a research-grade modulator of vascular potassium channels, advancing understanding of vasodilation in the context of renal and systemic vascular biology. This article goes beyond common applications to provide new insight into the mechanistic utility of Minoxidil sulphate in complex vascular assays.

• Phebestin and Bestatin: Advances in Aminopeptidase Inhibitor

  2026-07-30

  The referenced study introduces phebestin, a bestatin-related aminopeptidase inhibitor, demonstrating potent nanomolar antiplasmodial activity and safety in both in vitro and in vivo malaria models. These findings highlight the therapeutic potential of targeting parasite aminopeptidases and inform future research on novel antimalarial strategies.

• Quantitative In Vitro Metrics Refine Cancer Drug Response As

  2026-07-30

  Schwartz (2022) introduces a quantitative approach that distinguishes proliferative arrest from cell death in in vitro cancer drug evaluation, challenging the limitations of traditional viability metrics. This methodological advance enables more precise determination of drug efficacy, improving translational relevance for cancer research.

• Discovery of ATG9A and PTOV1 as Novel 14-3-3 Partners in Can

  2026-07-29

  This study identifies ATG9A and PTOV1 as previously unrecognized binding partners for 14-3-3 proteins, revealing new regulatory mechanisms in autophagy and oncogenic signaling. The findings advance our understanding of basal autophagy control and PTOV1-mediated cancer progression, offering new directions for targeting 14-3-3 interactions in cancer research.

• Taxus chinensis Fruit Extract Inhibits Neuroinflammation via

  2026-07-29

  The referenced study demonstrates that Taxus chinensis (Pilg.) Rehder fruit extract (TCFE) significantly attenuates aging-related behaviors and neuroinflammation in a D-galactose-induced mouse model by inhibiting microglial activation through the TLR4/NF-κB/NLRP3 pathway. This work advances mechanistic understanding of plant-derived TLR4 inhibition for neuroinflammation and aging research, and provides a comparative benchmark for selective TLR4 inhibitor applications.

• Streptavidin-Cy3: High-Fidelity Biotin Detection Reagent

  2026-07-28

  Streptavidin-Cy3 is a fluorescent streptavidin cy3 conjugate enabling precise, stable detection of biotinylated molecules in immunohistochemistry, immunofluorescence, and flow cytometry workflows. Its tetrameric structure ensures high-affinity, irreversible biotin binding, while Cy3 labeling delivers robust signal at 554/568 nm. APExBIO's K1079 reagent is validated for sensitive, reproducible research use.

• 2'3'-cGAMP (Sodium Salt): Beyond STING—New Frontiers in Cell

  2026-07-28

  Explore how 2'3'-cGAMP (sodium salt) not only activates the cGAS-STING pathway for type I interferon induction but also unveils a novel, STING-independent role in cell migration. Learn how these dual functions redefine assay design and therapeutic research.

• FCCP Uncoupling: Strategic Insights for Translational Metabo

  2026-07-27

  This article provides translational researchers with an in-depth, evidence-based perspective on leveraging FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) for advanced mitochondrial biology, metabolic regulation, and hypoxia pathway studies. By integrating mechanistic understanding, protocol best practices, and context from recent immunometabolic discoveries, we offer strategic guidance for designing impactful experiments that bridge cellular insights to clinical translation.

421 records 7/29 page Previous Next First page 上5页 678910 下5页 Last page